Although the majority of published studies suggesting a tumor promoting role for IL-1β, several studies have also demonstrated a tumor inhibiting effect, and the impact of IL1β signalling may vary depending on the cell type and the microenvironment (Dmitrieva-Posocco et al., 2019). This evidence concerns the gene IL1B and neoplasm.